Johanna Katharina Hohls1, Hans-Helmut König1, André Hajek2. 1. Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. 2. Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. a.hajek@uke.de.
Abstract
PURPOSE: To investigate the longitudinal association between trajectories (incidence, remission) of generalized anxiety disorder (GAD), major depression (MD) and change in quality of life (QoL) in adults aged 50 + , and to assess the symmetry in these relationships using observational study data. METHODS: Data were derived from two waves of The Irish Longitudinal Study on Aging (2014-2015, wave 3: n = 6400; 2016, wave 4: n = 5715), a nationally representative cohort of community-dwelling adults aged 50 +. GAD and MD were assessed by means of the short form of the Composite International Diagnostic Interview. QoL outcomes were assessed using the Control, Autonomy, Self-realization, and Pleasure scale (CASP-12 with two domains control/autonomy and self-realization/pleasure). Covariate-adjusted, asymmetric fixed effects panel regressions and post-estimation Wald tests were used for statistical analysis. RESULTS: Regarding incident disorders, only incident MD was significantly associated with a reduction in QoL over time (control/autonomy domain: b = - 0.74, SE: 0.30). Regarding remission, both remission of MD (b = 0.61, SE: 0.20) and remission of GAD (b = 0.61, 0.26) were significantly associated with an increase in the self-realization/pleasure domain over time. Subsequent Wald tests of the estimates were not significant, indicating symmetric effects. CONCLUSION: Particularly the remission of GAD and MD was associated with a significant improvement in one of the QoL domains, indicating domain- and trajectory-specific differences. However, symmetric effects observed in this study indicate that gains and losses in QoL associated with remission and incidence of GAD and MD are of similar magnitude in adults aged 50 +.
PURPOSE: To investigate the longitudinal association between trajectories (incidence, remission) of generalized anxiety disorder (GAD), major depression (MD) and change in quality of life (QoL) in adults aged 50 + , and to assess the symmetry in these relationships using observational study data. METHODS: Data were derived from two waves of The Irish Longitudinal Study on Aging (2014-2015, wave 3: n = 6400; 2016, wave 4: n = 5715), a nationally representative cohort of community-dwelling adults aged 50 +. GAD and MD were assessed by means of the short form of the Composite International Diagnostic Interview. QoL outcomes were assessed using the Control, Autonomy, Self-realization, and Pleasure scale (CASP-12 with two domains control/autonomy and self-realization/pleasure). Covariate-adjusted, asymmetric fixed effects panel regressions and post-estimation Wald tests were used for statistical analysis. RESULTS: Regarding incident disorders, only incident MD was significantly associated with a reduction in QoL over time (control/autonomy domain: b = - 0.74, SE: 0.30). Regarding remission, both remission of MD (b = 0.61, SE: 0.20) and remission of GAD (b = 0.61, 0.26) were significantly associated with an increase in the self-realization/pleasure domain over time. Subsequent Wald tests of the estimates were not significant, indicating symmetric effects. CONCLUSION: Particularly the remission of GAD and MD was associated with a significant improvement in one of the QoL domains, indicating domain- and trajectory-specific differences. However, symmetric effects observed in this study indicate that gains and losses in QoL associated with remission and incidence of GAD and MD are of similar magnitude in adults aged 50 +.
Keywords:
Generalized anxiety disorder; Longitudinal study; Major depression; Older adults; Quality of life; The Irish Longitudinal Study on Aging (TILDA)
Authors: Sylke Andreas; Holger Schulz; Jana Volkert; Maria Dehoust; Susanne Sehner; Anna Suling; Berta Ausín; Alessandra Canuto; Mike Crawford; Chiara Da Ronch; Luigi Grassi; Yael Hershkovitz; Manuel Muñoz; Alan Quirk; Ora Rotenstein; Ana Belén Santos-Olmo; Arieh Shalev; Jens Strehle; Kerstin Weber; Karl Wegscheider; Hans-Ulrich Wittchen; Martin Härter Journal: Br J Psychiatry Date: 2016-09-08 Impact factor: 9.319
Authors: Jonathan S Comer; Carlos Blanco; Deborah S Hasin; Shang-Min Liu; Bridget F Grant; J Blake Turner; Mark Olfson Journal: J Clin Psychiatry Date: 2010-08-24 Impact factor: 4.384
Authors: Alessandra Canuto; Kerstin Weber; Marc Baertschi; Sylke Andreas; Jana Volkert; Maria Christina Dehoust; Susanne Sehner; Anna Suling; Karl Wegscheider; Berta Ausín; Mike J Crawford; Chiara Da Ronch; Luigi Grassi; Yael Hershkovitz; Manuel Muñoz; Alan Quirk; Ora Rotenstein; Ana Belén Santos-Olmo; Arieh Shalev; Jens Strehle; Hans-Ulrich Wittchen; Holger Schulz; Martin Härter Journal: Am J Geriatr Psychiatry Date: 2017-09-05 Impact factor: 4.105
Authors: Hannie C Comijs; Jasper Nieuwesteeg; Rob Kok; Harm W van Marwijk; Roos C van der Mast; Paul Naarding; Richard C Oude Voshaar; Peter Verhaak; Margot Wm de Waal; Max L Stek Journal: BMC Psychiatry Date: 2015-02-12 Impact factor: 3.630